Clinical Report: Utilizing Antiretroviral Therapy for HIV Prevention and Transmission Reduction
Background
Antiretroviral therapy (ART) has been shown to significantly lower sexual HIV transmission, leading to major revisions in HIV treatment guidelines. The principle of undetectable = untransmittable (U=U) has become a cornerstone of HIV prevention strategies. However, recent reports indicate potential reductions in AIDS drug assistance programs, which could jeopardize progress made in controlling the HIV epidemic.
Data Highlights
No numerical data available in the source material, but qualitative findings indicate significant impacts of ART on HIV transmission.
Key Findings
ART can substantially lower sexual HIV transmission, as demonstrated in landmark clinical trials.
When viral suppression is achieved, there is no sexual transmission of HIV among partners.
Reductions in access to ART could lead to increased HIV infections in the U.S., as indicated by modeling studies.
Counterfactual modeling suggests that diminished ART access may reverse the successes of treatment as prevention (TasP).
PrEP has been effective in reducing HIV transmission rates since its introduction.
Clinical Implications
Maintaining viral suppression is essential for preventing sexual transmission of HIV.
Conclusion
Access to ART is critical for sustaining progress in HIV prevention and control in the United States.
